TITLE

How to define biomarkers of human T cell aging and immunocompetence?

AUTHOR(S)
Herndler-Brandstetter, Dietmar; Ishigame, Harumichi; Flavell, Richard A.
PUB. DATE
June 2013
SOURCE
Frontiers in Immunology;Jun2013, Vol. 4, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Opinion
ABSTRACT
In this article the authors discuss how aging affects the number, phenotype, and function of human T cells, and how to identify potential biomarkers of T cell aging. According to the authors, the decline in T cell number and function seems to be an important feature of human immune cell aging. The authors say that at the age of 50 years, 90 percent of functional tissue of thymus is lost; and this leads to a considerable shortage of T cells in the peripheral blood, lymph nodes, and bone marrow.
ACCESSION #
88031829

 

Related Articles

  • Plasma Cell.  // Encyclopedic Reference of Cancer;2001, p700 

    A definition of the term "plasma cell" is presented. It refers to terminally differentiated B cells that are responsible for immunoglobulin secretion and that mainly localize within bone marrow and lymph nodes.

  • In situ leukemic plasmacytoid dendritic cells pattern of chemokine receptors expression and in vitro migratory response. Bendriss-Vermare, N.; Chaperot, L.; Peoc'h, M.; Vanbervliet, B.; Jacob, M.-C.; Briere, F.; Bensa, J.-C.; Caux, C.; Plumas, J. // Leukemia (08876924);Sep2004, Vol. 18 Issue 9, p1491 

    Plasmacytoid dendritic cell (PDC) leukemia/lymphoma is a rare neoplasm presenting cutaneous lesions at the time of diagnosis, followed by dissemination to bone marrow, lymph nodes, and other lymphoid and nonlymphoid organs. Since these leukemic counterparts of human PDC are similar to normal...

  • Phenotype and morphology of murine NC-1.1 + natural cytotoxic cells. Brien, J. H.; Smart, Y. C.; Farrelly, M. L.; Burton, R. C. // Immunology & Cell Biology;Apr1994, Vol. 72 Issue 2, p161 

    The morphology and phenotype of cells identified by the anti-NC-1.1 mAb, 1C4, were studied in CBA and (CBA × C57BL/6) F1 mice. This mAb blocked splenic natural cytotoxic (NC) cell activity in vitro and in vivo. Single colour flow cytometric analysis showed that 6±1% of all CBA splenocytes...

  • Diffuse large B-cell lymphoma with distinctive patterns of splenic and bone marrow involvement: clinicopathologic features of two cases. Morice, William G.; Rodriguez, Fausto J.; Hoyer, James D.; Kurtin, Paul J. // Modern Pathology;Apr2005, Vol. 18 Issue 4, p495 

    Two unusual cases of large B-cell lymphoma with predominant splenic and bone marrow (BM) involvement and similar clinical and histopathologic features are described. Both patients presented with nonspecific constitutional symptoms, unexplained cytopenias, and splenomegaly. Splenectomy revealed...

  • Alloantigen recognition is critical for CD8 T cell-mediated graft anti-tumor activity against murine BCL1 lymphoma after myeloablative bone marrow transplantation. Pillai, A.; Teo, P.; George, T.; Mukhopadhyay, A.; Dejbakhsh-Jones, S.; Strober, S. // Bone Marrow Transplantation;Sep2007, Vol. 40 Issue 5, p487 

    The goal of the current study was to determine whether whole bone marrow cells or splenic CD8+ T cells from C57BL/6 (H-2b) donor mice, which are tolerant to BALB/c (H-2d) alloantigens, are capable of mediating graft anti-tumor activity against a BALB/c B-cell lymphoma after injection into...

  • Spontaneous Pneumothorax in a Case of Pulmonary Langerhans Cell Histiocytosis. Ciuche, Adrian; Nistor, Claudiu; Pantile, Daniel; Marin, Dragos; Tudose, Augustin // Romanian Journal of Medical Practice;2011, Vol. 6 Issue 3, p204 

    Langerhans Cell Histiocytosis (LCH) is a rare disease involving clonal proliferation of Langerhans cells, abnormal cells deriving from bone marrow and capable of migrating from skin to lymph nodes. Clinically, its manifestations range from isolated bone lesions to multisystem disease. The...

  • The efficacy of HGAL and LMO2 in the separation of lymphomas derived from small B cells in nodal and extranodal sites, including the bone marrow. Younes, Sheren F.; Beck, Andrew H.; Ohgami, Robert S.; Lossos, Izidore S.; Levy, Ronald; Warnke, Roger A.; Natkunam, Yasodha // American Journal of Clinical Pathology;May2011, Vol. 135 Issue 5, p697 

    We studied the efficacy of 2 germinal center B-cell markers, HGAL and LMO2, in the separation of lymphomas derived from small B cells, particularly follicular lymphoma (FL) and marginal zone lymphoma occurring in nodal, extranodal, splenic, and bone marrow sites using immunohistochemical...

  • Mastocytosis: current concepts in diagnosis and treatment. Escribano, L.; Akin, C.; Castells, M.; Orfao, A.; Metcalfe, D. // Annals of Hematology;Dec2002, Vol. 81 Issue 12, p677 

    Mastocytosis consists of a group of disorders characterized by a pathologic increase in mast cells in tissues including skin, bone marrow, liver, spleen, and lymph nodes. Mastocytosis is a rare disease. Because of this, general practitioners have limited exposure to its clinical manifestations,...

  • Tissue Biomarkers in Melanoma Patients Treated with TIL. Knol, Anne-Chantal; Nguyen, Jean-Michel; Pandolfino, Marie-Christine; Quéreux, Gaëlle; Brocard, Anabelle; Peuvrel, Lucie; Saint-Jean, Mélanie; Saiagh, Soraya; Khammari, Amir; Dréno, Brigitte // PLoS ONE;Dec2012, Vol. 7 Issue 12, p1 

    While treating stage III melanoma patients with autologous therapeutic TIL in an adjuvant setting, we previously reported a significant benefit of treatment on both progression-free survival and overall survival in patients with only one invaded lymph node (early stage III) compared to patients...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics